Deutsche Bank
BOLT icon

Deutsche Bank’s Bolt Biotherapeutics BOLT Stock Holding History

Deutsche Bank’s Portfolio BOLT Stock Details BOLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,221
Closed -$67K – 4138
2022
Q1 		$67K Buy
1,221
+526
+76% +$35.4K ﹤0.01% 3734
2021
Q4 		$68K Sell
695
-273
-28% -$51.8K ﹤0.01% 3856
2021
Q3 		$244K Buy
968
+624
+181% +$176K ﹤0.01% 3463
2021
Q2 		$106K Sell
344
-76
-18% -$30.9K ﹤0.01% 4117
2021
Q1 		$277K Buy
+420
New +$273K ﹤0.01% 3457

Other funds holding BOLT

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Deutsche Bank's BOLT Position: Q2 2022 in Review

Deutsche Bank sold out of Bolt Biotherapeutics (BOLT) in Q2 2022, closing a stake of 1,221 shares — an estimated $67K sold.

Deutsche Bank first reported a position in BOLT in Q1 2021 and held it in 5 quarters. The position peaked at $277K in Q1 2021. 61 funds tracked by Wall St. Rank hold BOLT as of Q2 2022.

  • Deutsche Bank reported no remaining Bolt Biotherapeutics position as of Q2 2022 after selling out during the quarter.
  • Deutsche Bank sold 1,221 Bolt Biotherapeutics shares in Q2 2022, an estimated $67K.
  • Deutsche Bank first reported a position in Bolt Biotherapeutics in Q1 2021 and held it in 5 quarters.
  • Deutsche Bank's Bolt Biotherapeutics position peaked at $277K in Q1 2021.
  • 61 funds tracked by Wall St. Rank held Bolt Biotherapeutics as of Q2 2022.

Based on Deutsche Bank's 13F filing for Q2 2022, filed 11 Aug 2022.